Low Dose Naltrexone
At low doses, naltrexone — an FDA-approved opioid antagonist — can reduce inflammation and autoimmunity activity. Known as low dose naltrexone (LDN), this medication has been proven to successfully treat and manage symptoms associated with a wide range of autoimmune diseases, ultimately giving patients a better quality of life.
Patients with autoimmune diseases tend to have lower levels of endorphins, hormones which create a general feeling of well-being. Low dose naltrexone partially blocks endorphins by attaching to opioid receptors. This signals the brain to increase production of endorphins. These “feel good” chemicals play an important role in maintaining proper immune function, preventing it from overreacting and causing symptom flare-ups.
Low dose naltrexone can be beneficial in treating the following autoimmune diseases:
- Hashimoto’s thyroiditis
- Rheumatoid arthritis
- Lupus
- Crohn’s disease
- Ulcerative colitis
- Multiple sclerosis
- Fibromyalgia
- Chronic fatigue
- Psoriasis and more